BioNexus Gene Lab Corp. Finance Lease, Liability, Current
BioNexus Gene Lab Corp. (BGLC) had Finance Lease, Liability, Current of $6.87 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:FinanceLeaseLiabilityCurrent · last filed 2026-08-14
- 2026-06-30: Finance Lease, Liability, Current $6.87K.
- 2026-03-31: Finance Lease, Liability, Current $7.77K.
- 2025-12-31: Finance Lease, Liability, Current $0.00.
- 2022-12-31: Finance Lease, Liability, Current $0.00.
| Period end | Finance Lease, Liability, Current |
|---|---|
| 2026-06-30 | $6.87K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $7.77K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-14 |
| 2022-12-31 | $0.00 10-K · filed 2023-03-31 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 |
| 2022-03-31 | $21.03K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $21.23K 10-K · filed 2023-03-31 |
| 2021-09-30 | $20.89K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $21.39K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $22.84K 10-Q · filed 2021-05-18 |
| 2020-12-31 | $25.05K 10-K · filed 2022-04-06 |
| 2020-09-30 | $19.89K 10-Q/A · filed 2020-11-09 |
| 2020-06-30 | $19.32K 10-Q · filed 2020-08-11 |
| 2020-03-31 | $19.22K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $20.20K 10-K · filed 2021-03-30 |
| 2019-09-30 | $19.52K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $19.50K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $19.63K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $19.13K 10-K · filed 2020-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |